|

Diabetes Clinical Trials in Memphis, TN

22 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
Pharmacy-led Transitions of Care Intervention to Improve Medication AdherenceN/A<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4<1 mi
Family Intervention for Black Teens With Type 1 DiabetesN/A<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3<1 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesPhase 3<1 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/A<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesPhase 2<1 mi
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer—<1 mi
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesPhase 2<1 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3<1 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarPhase 3<1 mi
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesPhase 3<1 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinPhase 3<1 mi
Delivering HOPE (Helping Women Optimize Prenatal Equity)N/A8 mi
Registry for Stage 2 Type 1 Diabetes—11 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 311 mi
Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot UlcersN/A11 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesPhase 318 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.